BIRMINGHAM, Alabama,
April 21, 2017 /PRNewswire/
-- BioGX, a developer and manufacturer of molecular
diagnostics CE-IVD tests has announced the establishment of
European operations based in Amsterdam, Netherlands. BioGX EU
operation is at the core of the company's growth strategy into the
European market with a goal to place sales, supply and support
resources closer to its European customers. BioGX
EU will provide direct support to customers in
Europe, the Middle East and Africa (EMEA) through
regional technical sales and field application resources.
According to Shazi Iqbal, Ph.D.,
CEO of BioGX, "BioGX EU operations will enhance the customer
experience and lower costs by eliminating the complexity and
expense associated with an international supply chain. BioGX
is well positioned to offer its full range of products and services
to customers throughout the EMEA region."
About BioGX
BioGX manufactures molecular
diagnostic CE-IVD tests and provides partner-specified formulation
and manufacturing services for custom molecular reagent
components. Operating in a cGMP compliant environment, BioGX
has a decade of experience in applying its proprietary
platform-agnostic reagent technology across a variety of real-time
PCR and Next Generation Sequencing platforms. The
Sample-Ready™ technology is applied
within clinical, food safety, pharma, and water quality
analysis industries worldwide. For its achievements
in exporting goods and services around the world, BioGX was
honored with the 2017 Alabama Governor's Trade Excellence
Award.
Logo -
https://mma.prnewswire.com/media/415789/BioGX_Logo.jpg